What's New?    Research   Subscription   Blog   About


Articles - Reports - Webinars - Community Subscription Topic Categories - Subscription Benefits and Roles

Jinfo SubscriptionMarket landscape - ebook sources and portals for biopharma and life sciences

Friday, 7th July 2017 Subscribe via RSS to get updates as soon as Subscription Reports are added Tweet about this item on Twitter Share on Facebook Share on LinkedIn


Jinfo Subscription Report

This report covers subscription sources for pharma and biotechnology ebooks and portals.

Pharma and biotechnology content: database platforms and content portals:

  • EBSCO Pharmaceutical EBSCO Biotechnology Source from EBSCO
  • Pharma + R&D Solutions from Elsevier
  • Pharmaceutical and Biomedical from ProQuest
  • Springer Nature for R&D - Pharma and Biotechnology from Springer Nature
  • Health from Wolters Kluwer

Pharma and biotechnology content: ebook sources:

  • AccessPharmacy from McGraw-Hill Medical
  • CRCnetBASE from Taylor & Francis Group

We provide a brief description of each product and a link to the product page and company's homepage, an overview of the typical users, key features/value, pricing and Jinfo coverage.

Produced by Helen Josephine.


How to access this report:

Jinfo Subscription

Access to this item is a benefit of a Jinfo Subscription.

If your organisation has a Jinfo Subscription then you can access this report in your MyJinfo account:

 Sign in to MyJinfo » 

If your organisation doesn't yet have a Jinfo Subscription, find out how it can help:

  1. Save time and money
  2. Re-invent information services
  3. Define, measure and communicate information value

 Learn more » 

Not sure if you're organisation has a Jinfo Subscription? Other questions?
Use the Live Text Chat button (bottom-right of this page) for immediate assistance, or the contact us.


About this report

Click to visit the Jinfo Blog Related Blog items:

 « All Subscription Reports 

What's New and Popular?

Latest Subscription content

Popular Blog content

Research Focus

 What else is new? »